Literature DB >> 18162979

Interinstitutional variation in the measurement of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee survey.

Kazunari Tanabe1.   

Abstract

Exact measurement of antiblood groups A and B antibody (Ab) titers is critical for successful ABO-incompatible living kidney transplantation (ABO-ILKT). However, no standard method for quantitative determination has yet been established. In most institutions performing ABO-ILKT, serial-doubling dilution of serum using a tube technique (TT) is a standard method for determining anti-ABO Ab titers, but there are very large interinstitutional variations in the titration of anti-ABO Abs using the TT. The Japanese ABO-Incompatible Transplantation Committee has conducted a national survey to measure anti-ABO Ab titers among more than 30 Japanese institutions. Interinstitutional differences between maximum and minimum values were as large as 32-fold in immunoglobulin M (IgM) and 256-fold in immunoglobulin G (IgG). There seem to be many detailed technical differences in the TT among the institutions. Consequently, in the present study we tried to find the most reliable technique for measuring anti-ABO Ab titers. We compared four different techniques, the TT, BioVue Column Agglutination Technology, DiaMed-ID Micro Typing System, and flow cytometry (FCM). Theoretically, FCM seems to be the most reliable technique because it does not require a great number of agents, each of which may affect the results. The FCM technique yielded a very consistent outcome in repeated measurements and it is one of the most objective techniques because measured data are automatically analyzed by a computer system. In our experience, FCM shows very good reproducibility and seems to be the best technique for titration since it can be performed without use of agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162979     DOI: 10.1097/01.tp.0000296018.82857.ef

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

Review 1.  Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy.

Authors:  Maria Sassi; Umberto Maggiore; Carlo Buzio; Massimo Franchini
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

Review 2.  ABO incompatible renal transplants: Good or bad?

Authors:  Masaki Muramatsu; Hector Daniel Gonzalez; Roberto Cacciola; Atsushi Aikawa; Magdi M Yaqoob; Carmelo Puliatti
Journal:  World J Transplant       Date:  2014-03-24

3.  Comparison of ABO antibody titers on the basis of the antibody detection method used.

Authors:  Seon Joo Kang; Young Ae Lim; Sae Yun Baik
Journal:  Ann Lab Med       Date:  2014-06-19       Impact factor: 3.464

4.  Current progress in ABO-incompatible kidney transplantation.

Authors:  Tai Yeon Koo; Jaeseok Yang
Journal:  Kidney Res Clin Pract       Date:  2015-08-20

5.  A Novel Method of CD31-Combined ABO Carbohydrate Antigen Microarray Predicts Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.

Authors:  Masayuki Tasaki; Hiroaki Tateno; Takashi Sato; Azusa Tomioka; Hiroyuki Kaji; Hisashi Narimatsu; Kazuhide Saito; Yuki Nakagawa; Toshinari Aoki; Masami Kamimura; Takashi Ushiki; Manabu Okada; Yuko Miwa; Kiyohiko Hotta; Yutaka Yoshida; Kota Takahashi; Yoshihiko Tomita
Journal:  Transpl Int       Date:  2022-03-23       Impact factor: 3.782

6.  Titers of ABO antibodies in group O blood donors.

Authors:  Natalia Dallaval Galvão de França; Mônica Caamaño Cristovão Poli; Patrícia Guilhem de Almeida Ramos; Cláudia Strang da Rocha Borsoi; Rafael Colella
Journal:  Rev Bras Hematol Hemoter       Date:  2011
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.